POP4 and craniopharyngioma: Furthermore, POP4, a GNG5 coexpressing promoter gene, is highly expressed in prostate cancer cells, while RIMS1, a GNG5 coexpressing suppressor gene, is lowly expressed in craniopharyngioma [30, 31].